Macchia, G., Lazzari, R., Colombo, N., Laliscia, C., Capelli, G., D'Agostino, G. R., Deodato, F., Maranzano, E., Ippolito, E., Ronchi, S., Paiar, F., Scorsetti, M., Cilla, S., Ingargiola, R., Huscher, A., Cerrotta, A. M., Fodor, A., Vicenzi, L., Russo, D., Borghesi, S., Perrucci, E., Pignata, S., Aristei, C., Morganti, A. G., Scambia, G., Valentini, V., Jereczek‐Fossa, B. A., & Ferrandina, G. (2020). a Large, Multicenter, Retrospective Study on Efficacy and Safety of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups. Oncologist, 25, e311–e320. http://access.bl.uk/ark:/81055/vdc_100149143131.0x00002c